Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives
Recent pharmacoepidemiologic studies suggest that pharmacological neuroenhancement (pNE) and mood enhancement are globally expanding phenomena with distinctly different regional characteristics. Sociocultural and regulatory aspects, as well as health policies, play a central role in addition to medi...
Saved in:
| Main Authors: | Johanna Daubner, Muhammad Imran Arshaad, Christina Henseler, Jürgen Hescheler, Dan Ehninger, Karl Broich, Oliver Rawashdeh, Anna Papazoglou, Marco Weiergräber |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Neural Plasticity |
| Online Access: | http://dx.doi.org/10.1155/2021/8823383 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EEG Radiotelemetry in Small Laboratory Rodents: A Powerful State-of-the Art Approach in Neuropsychiatric, Neurodegenerative, and Epilepsy Research
by: Andreas Lundt, et al.
Published: (2016-01-01) -
Altered Theta Oscillations and Aberrant Cortical Excitatory Activity in the 5XFAD Model of Alzheimer’s Disease
by: Magdalena Elisabeth Siwek, et al.
Published: (2015-01-01) -
Skin Lesions as Signs of Neuroenhancement in Sport
by: Sorana-Cristiana Popescu, et al.
Published: (2025-03-01) -
Limited Effects of an eIF2αS51A Allele on Neurological Impairments in the 5xFAD Mouse Model of Alzheimer’s Disease
by: Katharina Paesler, et al.
Published: (2015-01-01) -
Pharmacology /
by: Rosenfeld, Gary C.
Published: (2007)